ChiCTR2500106318 版本V1.0 版本创建时间2025/07/22 11:44:17 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500106318 

最近更新日期:

Date of Last Refreshed on:

2025-07-22 11:44:03 

注册时间:

Date of Registration:

2025-07-22 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

基于机器学习的结直肠癌患者癌因性疲乏风险预测模型的构建和验证

Public title:

Development and validation of a machine learning-based prediction model for the cancer-related fatigue in colorectal cancer patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

耳穴贴压干预结直肠癌患者癌因性疲乏的生物学机制及预测模型构建研究

Scientific title:

Biological Mechanisms of Auricular Point Pressing Intervention for Cancer-Related Fatigue in Colorectal Cancer Patients and Construction of a Predictive Model

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李艳 

研究负责人:

豆欣蔓 

Applicant:

Li Yan 

Study leader:

Dou Xinman 

申请注册联系人电话:

Applicant telephone:

+86 150 2997 5568

研究负责人电话:

Study leader's
telephone:

+86 139 0931 8917

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

liyanhl@lzu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

Douxm@lzu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

甘肃省兰州市城关区临夏路萃英门82号

研究负责人通讯地址:

甘肃省兰州市城关区临夏路萃英门82号

Applicant address:

No. 82, Cuiyingmen, Linxia Road, Chengguan District, Lanzhou City, Gansu Province

Study leader's address:

No. 82, Cuiyingmen, Linxia Road, Chengguan District, Lanzhou City, Gansu Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

兰州大学第二医院(第二临床医学院)

Applicant's institution:

The Second Hospital of Lanzhou University (Second Clinical Medical College)

研究负责人所在单位:

兰州大学第二医院(第二临床医学院)

Affiliation of the Leader:

The Second Hospital of Lanzhou University (Second Clinical Medical College)

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2025A-622

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

兰州大学第二医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of the Second Hospital of Lanzhou University

伦理委员会批准日期:

Date of approved by ethic committee:

2025-06-05 00:00:00

伦理委员会联系人:

焦作义

Contact Name of the ethic committee:

Jiao Zuoyi

伦理委员会联系地址:

甘肃省兰州市城关区临夏路萃英门82号

Contact Address of the ethic committee:

No. 82, Cuiyingmen, Linxia Road, Chengguan District, Lanzhou City, Gansu Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 931 894 3370

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

兰州大学第二医院(第二临床医学院)

Primary sponsor:

The Second Hospital of Lanzhou University (Second Clinical Medical College)

研究实施负责(组长)单位地址:

甘肃省兰州市城关区临夏路萃英门82号

Primary sponsor's address:

No. 82, Cuiyingmen, Linxia Road, Chengguan District, Lanzhou City, Gansu Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

甘肃

市(区县):

兰州

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

兰州大学第二医院(第二临床医学院)

具体地址:

甘肃省兰州市城关区临夏路萃英门82号

Institution
hospital:

The Second Hospital of Lanzhou University (Second Clinical Medical College)

Address:

No. 82, Cuiyingmen, Linxia Road, Chengguan District, Lanzhou City, Gansu Province

经费或物资来源:

Source(s) of funding:

None

研究疾病:

结直肠癌  

Target disease:

Colorectal Cancer

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

连续入组 

Study design:

Sequential 

研究目的:

采用5种机器学习算法构建、验证结直肠癌患者癌因性疲乏风险预测模型,选取最佳预测模型,使用列线图可视化呈现结直肠癌患者癌因性疲乏的概率。  

Objectives of Study:

Five machine learning algorithms were used to construct and validate a predictive model for the risk of cancer-caused fatigue in colorectal cancer patients, the best predictive model was selected, and the probability of cancer-caused fatigue in colorectal cancer patients was presented visually using a column-line graph.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.年龄>=18岁; 2.经病理活检确诊为结直肠癌或根据中国结直肠癌诊疗规范(2022 版)确诊为结直肠癌; 3.患者知晓自身病情,语言沟通能力正常; 4.知情同意本研究。

Inclusion criteria

1. Age>=18 years; 2. Confirmed colorectal cancer by pathological biopsy or colorectal cancer according to the Chinese Colorectal Cancer Diagnosis and Treatment Standards (2022 Edition); 3. The patient is aware of his or her condition and has normal language communication skills; 4. Informed consent to this study.

排除标准:

1.术前确认肿瘤广泛转移无法切除; 2.合并其他系统恶性肿瘤或重大躯体疾病; 3.有精神疾病史或存在认知障碍; 4.临床资料不完整; 5.正在参与其他研究。

Exclusion criteria:

1. Preoperative confirmation that the tumor has metastasized extensively and cannot be resected; 2. Combined with other systemic malignant tumors or major somatic diseases; 3. History of mental illness or cognitive impairment; 4. Incomplete clinical data; 5. Participating in other studies.

研究实施时间:

Study execute time:

From 2025-06-06 00:00:00 To 2026-02-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-07-28 00:00:00 To 2026-02-28 00:00:00

干预措施:

Interventions:

组别:

观察组

样本量:

562

Group:

Observation group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

甘肃 

市(区县):

兰州 

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

兰州大学第二医院(第二临床医学院) 

单位级别:

三甲 

Institution
hospital:

The Second Hospital & Clinical Medical School, Lanzhou University

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

甘肃 

市(区县):

兰州 

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

兰州大学第一医院(第一临床医学院) 

单位级别:

三甲 

Institution
hospital:

The Second Hospital of Lanzhou University (Second Clinical Medical College)

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

甘肃 

市(区县):

兰州 

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

甘肃省人民医院 

单位级别:

三甲 

Institution
hospital:

Gansu Provincial People's Hospital

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

甘肃 

市(区县):

兰州 

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

甘肃省肿瘤医院 

单位级别:

三甲 

Institution
hospital:

Gansu provincial cancer hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

癌因性疲乏

指标类型:

主要指标

Outcome:

Cancer-related fatigue

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-07-22 11:44:03